Laura Kananen

Laura Kananen

Auto-generated profile, based on publicly available information

Laura Kananen

Department of Medical Epidemiology and Biostatistics Karolinska Institutet Stockholm Sweden

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2013 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
CCCARDIoGRAM consortium
CARDIoGRAM consortium
VCVeryan Codd
Veryan Codd
CNChristopher Nelson
Christopher Nelson
EAEva Albrecht
Eva Albrecht
MMMassimo Mangino
Massimo Mangino
NSNilesh J Samani
Nilesh J Samani

25 May 2010 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LKLaura Kananen
Laura Kananen
ISIda Surakka
Ida Surakka
SPSami Pirkola
Sami Pirkola
Jaana SuvisaariJaana Suvisaari
Jaana Suvisaari
JLJouko Lönnqvist
Jouko Lönnqvist
Iiris HovattaIiris Hovatta
Iiris Hovatta
Accelerated leukocyte telomere shortening has been previously associated to self-perceived stress and psychiatric disorders, including schizophrenia and mood disorders. We set out to investigate whether telomere length is affected in patients with anxiety disorders in which stress is a known risk factor. We also studied the effects of childhood and recent psychological distress on telomere length. We utilized samples from the nationally representative population-based Health 2000 Survey that was carried out between 2000–2001 in Finland to assess major public health problems and their determinants. We measured the relative telomere length of the peripheral blood cells by quantitative real-time PCR from 321 individuals with DSM-IV anxiety disorder or subthreshold diagnosis and 653 matched controls aged 30–87 years, who all had undergone the Composite International Diagnostic Interview. While telomere length did not differ significantly between cases and controls in the entire cohort, the older half of the anxiety disorder patients (48–87 years) exhibited significantly shorter telomeres than healthy controls of the same age (P = 0.013). Interestingly, shorter telomere length was also associated with a greater number of reported childhood adverse life events, among both the anxiety disorder cases and controls (P = 0.005). Childhood chronic or serious illness was the most significantly associated single event affecting telomere length at the adult age (P = 0.004). Self-reported current psychological distress did not affect telomere length. Our results suggest that childhood stress might lead to accelerated telomere shortening seen at the adult age. This finding has potentially important implications supporting the view that childhood adversities might have a considerable impact on well being later in life.

14 February 2017 in Clinical Epigenetics
Verified
Journal Article
Open access
PDF file
TNTapio Nevalainen
Tapio Nevalainen
LKLaura Kananen
Laura Kananen
SMSaara Marttila
Saara Marttila
JJJuulia Jylhävä
Juulia Jylhävä
NMNina Mononen
Nina Mononen
MHMikko Hurme
Mikko Hurme
Human aging is associated with profound changes in one of the major epigenetic mechanisms, DNA methylation. Some of these changes occur in a clock-like fashion, i.e., correlating with the calendar age of an individual, thus providing a new aging biomarker. Some reports have identified factors associated with the acceleration of the epigenetic age. However, it is also important to analyze the temporal changes in the epigenetic age, i.e., the duration of the observed acceleration, and the effects of the possible therapeutic and lifestyle modifications. To address this issue, we determined the epigenetic age for a cohort of 183 healthy individuals using blood samples derived from two time points that were 25 years apart (between 15–24 and 40–49 years of age). Additionally, we also determined the epigenetic ages of 119 individuals in a cohort consisting of 90-year-old participants (nonagenarians). These were determined by using the Horvath algorithm based on the methylation level of 353 CpG sites. The data are indicated as the deviation of the epigenetic age from the calendar age (calendar age minus epigenetic age = delta age, ΔAGE). As obesity is often associated with accelerating aging and degenerative phenotypes, the correlation of the body mass index (BMI) with the ΔAGE was analyzed in the following three age groups: young adults, middle-aged, and nonagenarian. The data showed that BMI is associated with decreased ΔAGE, i.e., increased epigenetic age, in middle-aged individuals. This effect is also seen during the 25-year period from early adulthood to middle age, in which an increase in the BMI is significantly associated with a decrease in the ΔAGE. We also analyzed the association between BMI and epigenetic age in young and elderly individuals, but these associations were not significant. Taken together, the main finding on this report suggests that association between increased BMI and accelerated epigenetic aging in the blood cells of middle-aged individuals can be observed, and this effect is also detectable if the BMI has increased in adulthood. The fact that the association between BMI and epigenetic age can only be observed in the middle-aged group does not exclude the possibility that this association could be present throughout the human lifespan; it might just be masked by confounding factors in young adults and nonagenarian individuals.

1 March 2011 in Biological Psychiatry
Verified
Journal Article
Closed access
MMMargarita Muiños-Gimeno
Margarita Muiños-Gimeno
YEYolanda Espinosa-Parrilla
Yolanda Espinosa-Parrilla
MGMonica Guidi
Monica Guidi
BKBirgit Kagerbauer
Birgit Kagerbauer
TSTessa Sipilä
Tessa Sipilä
XEXavier Estivill
Xavier Estivill

14 March 2015 in BMC Genomics
Verified
Journal Article
Open access
PDF file
SMSaara Marttila
Saara Marttila
LKLaura Kananen
Laura Kananen
SHSergei Häyrynen
Sergei Häyrynen
JJJuulia Jylhävä
Juulia Jylhävä
TNTapio Nevalainen
Tapio Nevalainen
MHMikko Hurme
Mikko Hurme
Changes in DNA methylation are among the mechanisms contributing to the ageing process. We sought to identify ageing-associated DNA methylation changes at single-CpG-site resolution in blood leukocytes and to ensure that the observed changes were not due to differences in the proportions of leukocytes. The association between DNA methylation changes and gene expression levels was also investigated in the same individuals. We identified 8540 high-confidence ageing-associated CpG sites, 46% of which were hypermethylated in nonagenarians. The hypermethylation-associated genes belonged to a common category: they were predicted to be regulated by a common group of transcription factors and were enriched in a related set of GO terms and canonical pathways. Conversely, for the hypomethylation-associated genes only a limited set of GO terms and canonical pathways were identified. Among the 8540 CpG sites associated with ageing, methylation level of 377 sites was also associated with gene expression levels. These genes were enriched in GO terms and canonical pathways associated with immune system functions, particularly phagocytosis. We find that certain ageing-associated immune-system impairments may be mediated via changes in DNA methylation. The results also imply that ageing-associated hypo- and hypermethylation are distinct processes: hypermethylation could be caused by programmed changes, whereas hypomethylation could be the result of environmental and stochastic processes.

1 June 2010 in Biological Psychiatry
Verified
Journal Article
Closed access
TSTessa Sipilä
Tessa Sipilä
LKLaura Kananen
Laura Kananen
Dario  GrecoDario Greco
Dario Greco
JDJonas Donner
Jonas Donner
KSKaisa Silander
Kaisa Silander
Iiris HovattaIiris Hovatta
Iiris Hovatta